Skip to main content
Fig. 3 | Cancer Cell International

Fig. 3

From: Targeting WEE1 kinase as a p53-independent therapeutic strategy in high-risk and relapsed acute lymphoblastic leukemia

Fig. 3

Pharmacological blockade of WEE1 by AZD1775 abrogates the G2-M cell cycle checkpoint and induces S-phase cell cycle arrest of ALL blasts. A Cell cycle analysis of a TP53 isogenic NALM6 cell line model treated for 24 h with DMSO or increasing doses of AZD1775. Histograms are representative of three independent experiments. 2N DNA content indicates cells in G0 or G1 phase. 4N DNA content indicates cells in either G2 or M phase. Error bars show mean ± SD of at least three independent experiments. B Cell cycle analysis of high-risk TCF3::HLF-rearranged PDX#4 (TP53wt), relapsed B-other PDX#19-r (TP53wt), and relapsed hypodiploid PDX#10-r (TP53mut) treated with DMSO or increasing doses of AZD1775. Hypodiploid cell DNA content (< 2N) was normalized to diploid DNA content (2N). PDX#4, 24 h; PDX#19-r and PDX#10-r, 48 h. Data are representative of one independent experiment for each sample

Back to article page